MLTX Live signals | Maximize Profits with Getagraph.com

SELL 98966 min ago

@ $62.84

Issued: 14 Feb 2024 @ 12:52

Return: -34.72%

Previous signal: Feb 13 - 15:12

Previous signal: Buy

Return: 0.05 %

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 16:00):

Stats
Today's Volume	272 149
Average Volume	477 011
Market Cap	2.56B
EPS	$0 ( 2024-03-18 )
Next earnings date	( $-0.210 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-56.19
ATR14	$0.0820 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-27	Santos Da Silva Jorge	Sell	62 810	Class A ordinary shares, par value $0.0001 per share
2024-02-28	Santos Da Silva Jorge	Sell	56 065	Class A ordinary shares, par value $0.0001 per share
2024-02-29	Santos Da Silva Jorge	Sell	4 740	Class A ordinary shares, par value $0.0001 per share
2024-02-27	Reich Kristian	Sell	29 491	Class A ordinary shares, par value $0.0001 per share
2024-02-28	Reich Kristian	Sell	31 910	Class A ordinary shares, par value $0.0001 per share

INSIDER POWER
3.94
Last 99 transactions
Buy: 9 193 824 \| Sell: 8 000 713

Volume Correlation

Long: -0.42 (neutral)

Short: -0.86 (strong negative)

Signal:(42.554) Neutral

MoonLake Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MoonLake Correlation - Currency/Commodity

-0.06
( neutral )

0.87
( strong )

0.00
( neutral )

-0.40
( neutral )

0.28
( neutral )

0.72
( moderate )

MoonLake Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-13 158.00 (0.00 %)
EPS:	$-0.730

Q4	2023
Revenue:	$19 738.00
Gross Profit:	$16 449.00 (83.34 %)
EPS:	$-0.120

Q3	2023
Revenue:	$0
Gross Profit:	$-3 290.00 (0.00 %)
EPS:	$-0.180

Q2	2023
Revenue:	$0
Gross Profit:	$-3 289.00 (0.00 %)
EPS:	$-0.230

Financial Reports:

No articles found.

MoonLake

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.